home > bioproject > PRJEB32037
identifier PRJEB32037
type bioproject
sameAs
organism
title WGS to predict drug susceptibility against first-line anti-tuberculosis drugs
description We investigated the reliability of WGS to predict drug susceptibility and analysed the discrepancies between WGS and phenotypic DST by MGIT against the first-line drugs rifampicin, isoniazid, ethambutol, and pyrazinamide. In total 1,136 MTBC isolates from 2016/2017 were included. The negative predictive value of WGS was > 99.3% for all four first-line antibiotics. The majority of discrepancies for isoniazid and ethambutol were explained by growth at the concentrations just below the critical concentrations, and for rifampicin by prolonged incubation, which are sometimes missed in the MGIT.
data type Other
organization
publication
properties 
{...}
dbXrefs
sra-run  ERR3275156ERR3275157ERR3275158ERR3275159ERR3275160ERR3275161ERR3275162ERR3275163ERR3275164ERR3275165 More
sra-submission  ERA1825636
biosample  SAMEA5561383SAMEA5561384SAMEA5561385SAMEA5561386SAMEA5561387SAMEA5561388SAMEA5561389SAMEA5561390SAMEA5561391SAMEA5561392 More
sra-study  ERP114661
sra-sample  ERS3363416ERS3363417ERS3363418ERS3363419ERS3363420ERS3363421ERS3363422ERS3363423ERS3363424ERS3363425 More
sra-experiment  ERX3302029ERX3302030ERX3302031ERX3302032ERX3302033ERX3302034ERX3302035ERX3302036ERX3302037ERX3302038 More
distribution JSONJSON-LD
Download
bioproject.xml  HTTPS FTP
status public
visibility unrestricted-access
dateCreated 2019-04-11T00:00:00Z
dateModified 2019-04-11T00:00:00Z
datePublished